Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Galux has announced a breakthrough in AI-driven antibody design, successfully creating antibodies for six therapeutic targets, including one without an experimentally resolved structure.
DeCloak Intelligences and NTUH's Hsin-Chu Branch will present their AI privacy healthcare system at NVIDIA GTC 2025, featuring real-time de-identification image processing to enhance patient safety.
Nimblemind.ai has raised $2.5 million to improve its AI-powered data infrastructure for healthcare providers, as announced in a press release. The funding will help transform unstructured healthcare data into AI-ready formats.
Biolexis Therapeutics has confirmed a novel allosteric activation mechanism for the GLP-1 receptor using its AI-driven platform, MolecuLern, as announced in a press release.
Porter has announced a growth investment from Eir Partners to enhance its AI-based care coordination services, focusing on improving patient outcomes and expanding its technology offerings.
Caliber has launched four new AI-driven solutions to enhance pharmaceutical manufacturing and quality control, announced in a press release. These innovations aim to position the company at the forefront of the Pharma 4.0 revolution.
Olympus Corporation has announced the launch of its first AI-powered clinical decision tool in partnership with Ziosoft, focusing on liver, lung, and kidney procedures.
Shiru and GreenLab have announced a strategic partnership to commercialize novel food proteins using a corn-based expression system, enhancing sustainable protein production.
Turacoz Group presented its AI-driven living systematic reviews at the World EPA 2025 Conference, highlighting advancements in evidence synthesis and healthcare decision-making.
Pramana and ARUP Laboratories have partnered to digitize pathology slides and develop AI algorithms for hematopathology, enhancing diagnostic precision and efficiency.
Caristo Diagnostics has received FDA 510(k) clearance for its AI-powered CaRi-Plaque technology, designed to aid in the diagnosis of coronary artery disease by analyzing coronary plaque.
Body Vision Medical has received regulatory approval from the Therapeutic Goods Administration for its LungVision imaging system in Australia, enhancing lung cancer diagnosis capabilities.
Reclaim Health has integrated its AI-powered healthcare financial management platform with WEX's benefits administration solution, aiming to improve decision-making for employers and employees.
moveUP.care has announced its acquisition of Deep Structure.ai, a US-based digital health company specializing in AI-driven orthopedic care, to strengthen its capabilities and expand its presence in the US.
Tethis and Sheba Medical Center have announced a research collaboration to advance AI-powered liquid biopsy technology for rectal cancer, focusing on circulating tumor cells and ctDNA.
RamSoft has partnered with CARPL.ai to integrate over 150 AI applications into its PowerServer and OmegaAI platforms, enhancing radiology workflows.
ARUP Laboratories has expanded its AI-augmented screening tool to include wet-mount slides, enhancing the detection of gastrointestinal parasites.
Paradigm Health has appointed Dr. David Shulkin to its advisory board to enhance AI-driven cancer clinical trials in rural America, as announced in a press release.
Modern Sports Medicine & Wellness has announced a partnership with NeuralCure AI to integrate AI-powered decision support into non-surgical orthobiologic treatments, enhancing patient care and telehealth services.
Pusan National University researchers have developed the Hypergraph Interaction Transformer, an AI model that accelerates the identification of therapeutic gene targets using hypergraphs.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
